Current immunotherapeutic approaches in DLBCL: the value of CAR-T cells and bispecific antibodies

(2:52)

Current status of immunotherapy for advanced melanoma

(2:32)

The current immunotherapeutic landscape for treatment of DLBCL

(1:53)

The current landscape for sarcoma immunotherapy treatments

(1:49)

Current Immunotherapy Options for Advanced Endometrial Cancer- 2024 Ovarian Cancer Program

(4:27)

Current and Emerging Immunotherapeutic Strategies in Melanoma

(1:27)

Immunotherapy for lung cancer: current landscape and challenges

(2:33)

Current and Emerging Immunotherapeutic Strategies in Melanoma

(2:14)

HRD: Diagnostic and treatment implications in gynaecological cancer

(1:15:6)

The current status and future perspectives in immunotherapy

(2:13)

Current status and future perspectives in immunotherapy for glioblastoma

(2:44)

New immunotherapies in trial

(4:27)

Immunotherapeutic Management of Hepatocellular Carcinoma: Current Options and Future Possibilities

(19:9)

Gastroesophageal Cancer: Current Positioning of Immunotherapy

(30:31)

Immunotherapy: Immune Based Therapies, Vaccines, and Current Research

(55:49)

Current and future approaches of immunotherapy for NSCLC

(1:4)

Current and future trends in immunotherapy for MSI-H colorectal cancer

(1:14)

Current Role of Immunotherapy in EGFR-Mutant Lung Cancer

(48)

5 Current Trends of Cancer Immunotherapy 2022 I Atlantis Bioscience

(2:49)

Current trends on cancer immunotherapy

(3:52)